SymBiosis
Alexis Ivy is currently a Venture Fellow at SymBiosis since January 2022. Prior to this role, Alexis worked as a Graduate Research Assistant at the University of Arkansas. Alexis holds a Bachelor of Science in Chemical Engineering from The University of Alabama and is currently pursuing a Doctor of Philosophy (PhD) in Biomedical/Medical Engineering at the University of Arkansas, expected to graduate in May 2023.
This person is not in any teams
SymBiosis
SymBiosis is an investment firm focused on advancing biotherapeutics innovations for serious and life-threatening diseases. The firm invests in groundbreaking medicines across disease area, financing stage, and geography, with a focus on programs in, or about to enter, human trials. SymBiosis currently manages a portfolio of more than 30 investments and has significant, long-term capital commitments to fund future investments.